Skip to main content

Fragile X syndrome Archives

New research on Fragile X syndrome reinforces importance of early detection

Aug. 25, 2017—New insights into the long-lasting effects of Fragile X syndrome on connections in the brain during early development highlight the importance of early detection and treatment.

Read more


Vanderbilt senior wins Genetics Society award

Apr. 12, 2013—Samuel Friedman, a senior from Plymouth, Ma., majoring in molecular and cellular biology, recently won a Victoria Finnerty Undergraduate Travel Award from the Genetics Society of America. The award allowed Friedman to present his research at the 54th Annual Drosophila Research Conference in Washington, D.C.

Read more


Nobel in Chemistry reveals VU ties that bind

Oct. 18, 2012—Several Vanderbilt researchers have collaborated with this year's Nobel Chemistry winners.

Read more


Vanderbilt Kennedy Center to hold free symposium on fragile X

Jul. 30, 2012—The Vanderbilt Kennedy Center’s Fragile X Treatment Research Program will present information and current research on fragile X at a symposium titled “Transitions and Adulthood.” The free event is Monday, Aug. 20, at 6:30 p.m. at the Holiday Inn Nashville-Vanderbilt and is open to family members, friends, researchers, clinicians, students, community professionals and disability advocates....

Read more


New schizophrenia drug candidates entering prep for first-in-human testing

Dec. 15, 2011—The progression of new drug candidates for schizophrenia with partner Janssen Pharmaceutica is the latest evidence that a new collaborative model for drug discovery pioneered at Vanderbilt may help identify and develop innovative candidate drugs for treatment of major brain disorders.

Read more


Researchers strive to refill drug discovery ‘pipeline’

Oct. 3, 2011—Researchers at Vanderbilt University Medical Center have made substantial progress in developing potential new treatments for Parkinson’s disease, schizophrenia and fragile X syndrome, the most common genetic form of autism.

Read more


Milestone in development of new treatment for ‘fragile X’

Sep. 15, 2011—Researchers at Vanderbilt University Medical Center, in collaboration with Seaside Therapeutics in Cambridge, Mass., have achieved a milestone in the development of a potential new treatment for fragile X syndrome, the most common genetic cause of autism.

Read more


Fragile X forum June 20

Jun. 14, 2011—Learn more about Fragile X syndrome and the advancements in research.

Read more


Forum on fragile X syndrome June 20

May. 31, 2011—Panelists will discuss how research findings are improving clinical care of this inherited disability.

Read more


Neuroscience drug discovery center opens at Vanderbilt

Mar. 11, 2011—Vanderbilt University Medical Center has established a new Center for Neuroscience Drug Discovery to accelerate research that may lead to new treatments for Parkinson's disease, schizophrenia and other disorders of the brain.

Read more